We applied enzymatic hydrolysis and tangential flow filtration (TFF) to purify a novel anticancer peptide from Mytilus coruscus (M. coruscus) and investigated its anticancer properties. To prepare the peptide, eight proteases were employed for enzymatic hydrolysis. Pepsin hydrolysates, which showed clearly superior cytotoxic activity on prostate cancer cells, were further purified using a flow filtration system using a TFF and consecutive chromatographic methods. Finally, a novel anticancer peptide was obtained, and the sequence was identified as Ala-Phe-Asn-Ile-HisAsn-Arg-Asn-Leu-Leu. The peptide from M. coruscus effectively induced cell death on prostate, breast and lung cancer cells but not on normal liver cells. This is the first report of an anticancer peptide derived from the hydrolysates of M. coruscus.
In recent years, peptides generated by the digestion of various proteins, including animal and plant sources, have been found to possess biofunctional activity [6] . These peptides are inactive within the sequences of their parent proteins and are released during gastrointestinal digestion or food processing [16] . Once such bioactive peptides are liberated, depending on their structural, compositional, and sequential properties, they may exhibit various biofunctional activities. The functional properties of a protein can be improved by enzymatic hydrolysis under controlled conditions. Indeed, hydrolytic processes have been developed to convert under-utilized materials into marketable and acceptable forms, which can then be widely used in food rather than as animal feed or fertilizer. Hydrolysis potentially influences the molecular size, hydrophobicity, and polar groups of hydrolysates [13] . Furthermore, the characteristics of a hydrolysate directly affect its functional properties and potential as food ingredients. These functional properties of proteins can be improved by specific enzymatic hydrolysis under controlled conditions [6] . Several studies have reported antioxidant peptides derived from seafood sources and their potential for use as alternative antioxidants [8, 22, 24] . However, few studies have evaluated antioxidant properties of peptides derived from enzymatic hydrolysates of M. coruscus.
M. coruscus belongs to the family Mytilidae, one of the main cultured species of marine shellfish in Korea, and has been used as food and medicine for thousands of years. As a traditional medicine, it has been frequently prescribed by practitioners to regulate the functions of the liver and kidneys, strengthen the immune system, for the treatment of male impotence, female menoxenia, and other disorders [14] . Until now, little attention had been paid to the peptide in this bivalve. Few reports have investigated the structure and bioactivity of other shellfish. Mytilan, isolated from the mantle of the mussel Crenomytilus grayanus, possessed high immunomodulating activity [21] . A polysaccharide (glycogen), extracted from Perna canaliculus, has been found to have an anti-inflammatory activity [18] . A heparinlike substance able to bind antithrombin III (ATIII), isolated from the marine clam Anomalocardia brasiliana, was found to have potent anticoagulant activity [2] . Research about the biological activity of the mussel has *Corresponding author Phone: +82-43-840-3588; Fax: +82-43-852-3616; E-mail: parkpj@kku.ac.kr been undertaken by labs from New Zealand, Bulgaria, Russia, Italy, and other countries [12, 20, 29] . Many of the previous studies were related to the cultivation conditions, and there is little research about the mussel cultivated in Korea and its anticancer activity. Meanwhile, prostate cancer is one of the most common malignant tumors; surgical removal and chemotherapy have been the mainstay of prostate cancer treatment. However, conventional treatments have not improved the survival rate over the past two decades [31] . The objective of this work was, therefore, to identify and investigate the effect of the cancer toxicity components extracted from M. coruscus. 
MATERIALS AND METHODS

Materials
Preparation of Enzymatic Hydrolysates from M. coruscus
Prior to enzymatic hydrolysis, M. coruscus was pulverized into a powder using a grinder and the enzymatic hydrolysates were obtained according to the method described by Park et al. [23] . Briefly, 100 ml of 0.1 M phosphate buffer solution was added to 2 g of powder sample, and then 40 µl (or mg) of each enzyme was added after a 30 min pre-incubation. The enzymatic hydrolysis reactions were carried out for 8 h to achieve an optimum hydrolytic level and immediately heated to 100 
Purification of Anticancer Peptides from M. coruscus
Fractions from a TFF system. The enzymatic hydrolysates of M. coruscus were fractionated through ultrafiltration (UF) membranes with a range of MWCO of 30, 10, and 5 kDa, using a TFF system. The fractions were designated as follows: MWCO I referred to the filtrates that were not passed through a 30-K MWCO membrane. MWCO II referred to the filtrates that were passed through a 30-K MWCO membrane but not passed through a 10-K MWCO membrane. MWCO III referred to the filtrates that were passed through a 10-K MWCO membrane but not passed through a 5-K MWCO membrane. MWCO IV referred to filtrates that were passed through a 5-K MWCO membrane. All fractions recovered were lyophilized in a freeze drier for 3 days.
Ion-Exchange Chromatography Using a Diethylaminoethyl (DEAE)-Sephacel
Among the eight enzymatic hydrolysates, pepsin hydrolysates, showing the toxicity activity in cancer cells, were selected for further purification. Four milliliter of MWCO IV (250 mg/ml) was loaded onto a DEAE-Sephacel ion-exchange column (74 × 280 mm), equilibrated with 1.0 M Tris-HCl buffer (pH. 8.0) and eluted with a linear gradient of NaCl (0-1.0 M) in the same buffer at a flow rate of 80 ml/h. Each fraction was monitored at 280 nm, collected at a volume of 3.0 ml, and desalted using dialysis membrane, and then lyophilized, and the anticancer activity was investigated. Each fraction was pooled, dialyzed overnight, and lyophilized for 3 days. The strongest anticancer fraction was lyophilized, and chromatography was conducted as the next step.
High-Performance Liquid Chromatography (HPLC)
The fraction exhibiting the highest anticancer activity was further purified using reversed-phase HPLC (RP-HPLC) on a C 18 column (20 × 250 mm) with a linear gradient of acetonitrile (0-60%) at a flow rate of 2.5 ml/min. The elution peaks were detected at 215 nm, concentrated using a rotary evaporator, and lyophilized for 3 days. For further purification, the fraction with the highest toxicity activity from RP-HPLC was loaded onto a C 18 column (4.0 × 250 mm) with a linear gradient of acetonitrile (0-70%) at a flow rate of 0.5 ml/min. The fraction with the highest toxicity activity from RP-HPLC was further purified by loading it onto a C 18 column (4.0 × 250 mm) with a linear gradient of acetonitrile (0-30%) at a flow rate of 0.2 ml/min. Potent peaks were collected, evaluated for anticancer activity, and then lyophilized. The final purified peptides were analyzed for amino acid sequence.
Identification of the Amino Acid Sequence of the Purified Peptide Amino acid sequences of the purified peptides were determined using a GC/LC Triple Quadrupole Mass Spectrometer (Shinhan Scientific, Seoul, South Korea) by the Korea Basic Science Institute. The purified peptide was searched against the NCBI nonredundant peptide database.
Cell Cuture
Prostate cancer cells were cultured and maintained in RPMI medium 1640, and normal liver cells, and breast, lung, and liver cancer cells were cultured and maintained in DMEM supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, and 10% FBS and maintained at 37 o C under a humidified atmosphere with 5% CO 2 . All the treatments were performed at 30% confluence.
Apoptosis Analysis
For apoptosis analysis, the harvested cells were fixed with ethanol (containing 0.5% Tween-20) for 24 h, incubated with 50 µg/ml propidium iodide (PI) and 1 µg/ml RNase A at 37 o C for 30 min, and analyzed by flow cytometry, using a FACScan (BD, Franklin Lakes, NJ, USA). The cells belonging to the sub-G1 population were considered apoptotic cells, and the percentage of each phase of the cell cycle was determined as the apoptosis rate. The apoptosis rate was expressed as LC 50 (mg/ml), the concentration of the anticancer peptide that results in 50% death of cancer cells.
Statistical Methods
Statistical analysis of data was carried out with the GraphPad PRISM program (GraphPad Software, Inc., San Diego, CA, USA). Multiple group data were analyzed using a one-way analysis of variance followed by Bonferroni post hoc tests. All results are expressed as mean ± standard deviation of comparative fold differences. Data are representative of three independent experiments.
RESULTS AND DISCUSSION
Preparation of Protein Hydrolysates from M. coruscus and Their Anticancer Properties
Many bioactive peptides have been extracted by enzymatic hydrolysis using various enzymes. One of the approaches for the effective release of bioactive peptides from protein sources is enzymatic hydrolysis, which is widely applied to improve and upgrade the functional and nutritional properties of protein [9] . In the present study, we utilized eight proteases to extract anticancer peptides from M. coruscus, and we evaluated their anticancer activity as determined by their toxicity capacity in cancer cells. As shown in Table 1 , among the eight proteases, the pepsin hydrolysates from M. coruscus showed the highest anticancer activity, resulting in apoptosis rates with LC 50 values of 2.85 mg/ml in a dose-dependent manner.
Purification and Characterization of an Anticancer
Peptide from M. coruscus Dead-end filtration results in a buildup of product on the membrane surface that may damage the product, lower recovery, and foul the membrane. Fouling impedes the filtration rate until it eventually stops [25] . On the contrary, TFF involves the recirculation of the retentive across the surface of the membrane. This gentle cross flow feed acts to minimize membrane fouling, maintains a high filtration rate, and provides higher product recovery, since the sample remains safely in solution [17, 30] . Accordingly, in this study, we chose a TFF system to separate pepsin hydrolysates of different molecular weights. To purify the anticancer peptide, the pepsin hydrolysate of M. coruscus was filtered through 30-K MWCO, 10-K MWCO, and 5-K MWCO membranes, consecutively. The 50% lethal concentrations of the MWCO I, MWCO II, MWCO III, and MWCO IV against prostate cancer cells, PC-3, were 4.20, 2.85, 2.95, and 2.42, respectively ( Table 2 ). Many studies have reported that short peptides exert greater anticancer potential than other bioactive properties [3] , and our results agree with the earlier reports.
The MWCO IV fraction exhibited the highest toxicity activity and was selected for further study. MWCO IV was dissolved in deionized water, and loaded onto a DEAESephacel anion-exchange column with a linear gradient of NaCl (0-1.0 M). The elution peaks were monitored at 280 nm, and each 3.0 ml fraction was collected and fractionated into three subfractions (Fig. 1A) . Each fraction was pooled, lyophilized, and measured for anticancer activity as the apoptosis rate. As a result, peak C potentially induced toxicity in cancer cells, and the LC 50 value was 2.04 mg/ml (Fig. 1A) . Therefore, fraction C was selected for the next step. The lyophilized active fraction D was further separated by RP-HPLC on a C 18 column (20 × 250 mm) using a linear gradient of acetonitrile (0-60%), and the fraction was divided into two subfractions (C-I and C-II) (Fig. 1B) . Fraction C-I exhibited the strongest anticancer activity, with a LC 50 value of 1.70 mg/ml. Fraction C-I was further subjected to a second separation by RP-HPLC on a C 18 column (4.0 × 250 mm) using a linear gradient of acetonitrile (0-30%), and fractionated into four subfractions (Fig. 1C) . The fractions were pooled and lyophilized. Of the four fractions collected, fraction C-I-ii exhibited the strongest toxicity activity, with an LC 50 value of 1.21 mg/ml. Finally, we obtained the purified anticancer peptide (Fig. 1D) . The amino acid sequences of the purified peptides were measured by a GC/LC Triple Quadrupole Mass Spectrometer (Shinhan Scientific, Seoul, South Korea), and the sequence was Ala-Phe-Asn-Ile-His-Asn-Arg-Asn-Leu-Leu. In addition, the toxicity activity of the peptide was investigated, and the LC 50 values were 0.94, 1.41, and 1.22 mg/ml on prostate cancer (PC-3), lung cancer (A549), and breast cancer (MDA-MB-231) cells, respectively (Table 3) .
Moreover, the peptide did not affect the normal liver cells, Chang (Fig. 2D) . The activity of the final fractions increased approximately by 3-fold as compared with that of the crude hydrolysates. These activities are stronger than other enzymatic hydrolysates [5] . Recently, it has been proposed that the potential of food to provide biologically active peptides [10] should also be considered. Peptides derived from food may have diverse biological activities of interest for human health such as antihypertensive, antithrombotic, immunomodulatory, antimicrobial, and anticancer activities [10, 11] . Dietary consumption of bioactive components appears to provide further benefits to the endogenous defense system in the fight against exogenous attack [15] . Recent studies have shown that peptides with anticancer properties can be released from food sources such as milk casein [28] and soy protein [3] . Moreover, cationic amphipathic peptides, such as cecropins, defensins, and mellitin, also induce cell death in prokaryotic and eukaryotic cells by increasing membrane permeability [4] . This increased permeability may lead to cell lysis or, alternatively, may produce subtle changes in the membrane barrier function and promote cell death [26] . It has also been shown that the anticancer activities of natural and synthetic cationic peptides exhibit therapeutic activity in murine models of human tumors [1, 19, 27] . Many of these properties are attributed to physiologically active peptides in protein molecules [11] . These peptides are either present in the raw material or are generated during food processing and protein hydrolysis by digestive enzymes.
The most common way to produce bioactive peptides is through enzymatic hydrolysis of whole protein molecules. Many of the known bioactive peptides have been produced using gastrointestinal enzymes, usually pepsin and trypsin.
Other digestive enzymes and different enzyme combinations of proteinases -including alcalase, chymotrypsin, pancreatin, pepsin, and thermolysin as well as enzymes from bacterial and fungal sources -have also been utilized to generate bioactive peptides from various proteins [7] . In this study, among the various hydrolysates, pepsin hydrolysates The cells were treated with 0.5 mg/ml of the anticancer peptide for 24 h. The arrows indicate the apoptotic peak.
showed the highest anticancer activity. The anticancer peptide was derived from enzymatic hydrolysates, and therefore it resolved water and the yield was higher than other methods. In addition, the peptide can be effectively digested and absorbed because it is hydrophilic. It means that the peptide is easy to apply for commercial approaches. The search for beneficial agents led to a novel anticancer peptide from M. coruscus. The toxicity ability of enzymatic hydrolysates from M. coruscus were examined by a flow cytometry, and the resulting anticancer peptide was purified from pepsin hydrolysates using consecutive chromatographic methods (Fig. 3) . Finally, we obtained an anticancer peptide, and the sequence was found to be Ala-Phe-Asn-Ile-His-Asn-Arg-Asn-Leu-Leu. The results showed that the novel anticancer peptide efficiently induced toxicity in cancer cells but not in normal liver cells. This is the first report of an anticancer peptide derived from the hydrolysates of M. coruscus. 
